X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2023/06/21/2691932/0/en/Innovation-Pharmaceuticals-Provides-Update-on-U-S-Patent-Applications-Covering-Use-of-Brilacidin-in-Inflammatory-Bowel-Diseases-Coronaviruses-and-Fungal-Diseases.html
https://www.globenewswire.com/news-release/2022/12/13/2572586/0/en/Innovation-Pharmaceuticals-Reports-New-In-Vivo-Antifungal-Data-Showing-Brilacidin-s-Potential-for-Treating-Fungal-Keratitis.html
https://www.accesswire.com/706735/Innovation-Pharmaceuticals-Announces-New-Antiviral-Research-on-Brilacidin-in-Bunyaviruses-and-Alphaviruses-to-be-Presented-at-the-2022-Military-Health-System-Research-Symposium
https://www.accesswire.com/706249/Innovation-Pharmaceuticals-Reports-Brilacidin-Inhibits-Omicron-Delta-Gamma-and-Alpha-SARS-CoV-2-Variants-Based-on-In-Vitro-Testing-by-NIHNIAID-Sponsored-and-Rutgers-University-Researchers
https://finance.yahoo.com/news/database-lock-completed-innovation-pharmaceuticals-113000231.html
https://www.globenewswire.com/news-release/2021/06/18/2249692/0/en/Innovation-Pharma-Announces-New-Brilacidin-Antiviral-Research-on-Non-SARS-CoV-2-Endemic-Viral-Diseases-to-be-Presented-at-the-2021-Military-Health-System-Research-Symposium.html
https://www.biospace.com/article/releases/innovation-pharma-provides-study-details-for-ongoing-phase-2-clinical-trial-of-brilacidin-in-hospitalized-covid-19-patients/
https://www.biospace.com/article/releases/innovation-pharmaceuticals-and-george-mason-university-announce-public-release-of-laboratory-testing-results-demonstrating-brilacidin-s-covid-19-treatment-potential/
https://www.globenewswire.com/news-release/2020/09/15/2093822/0/en/Laboratory-Testing-of-Brilacidin-for-COVID-19-in-Combination-with-Remdesivir-Reduces-Viral-Load-by-Nearly-100-Percent.html
https://www.pharmaceutical-technology.com/news/innovation-brilacidin-preclinical/
https://www.globenewswire.com/news-release/2020/08/24/2082555/0/en/COVID-19-Drug-Candidate-Brilacidin-Achieves-a-Selectivity-Index-Among-the-Highest-Reported-Exhibiting-Potent-Anti-SARS-CoV-2-Activity-at-Low-Concentrations-Clinical-Trial-Forthcomi.html
https://www.globenewswire.com/news-release/2020/07/20/2064267/0/en/Innovation-Pharmaceuticals-Brilacidin-Inhibits-Novel-Coronavirus-COVID-19-by-Almost-90-at-the-Lowest-Concentration-Tested-to-Date-in-a-Human-Lung-Cell-Line.html
http://www.ipharminc.com/press-release/2020/7/7/in-vitro-testing-of-innovation-pharmaceuticals-brilacidin-for-covid-19-shows-consistent-anti-sars-cov-2-efficacy-manufacturing-preparation-underway-for-covid-19-clinical-trial
http://www.ipharminc.com/press-release/2020/6/11/innovation-pharmaceuticals-collaborating-with-regional-biocontainment-lab-on-grant-application-to-research-brilacidin-as-a-pan-coronavirus-therapeutic
http://www.ipharminc.com/press-release/2020/5/26/innovation-pharmaceuticals-receives-data-from-public-health-research-institute-showing-brilacidin-inhibits-sars-cov-2-covid-19-in-a-human-cell-line
https://www.globenewswire.com/news-release/2020/05/19/2035552/0/en/Innovation-Pharmaceuticals-Brilacidin-Reduces-Viral-Titer-of-SARS-CoV-2-COVID-19-by-75-percent-After-Only-1-Hour-of-Preincubation-in-In-Vitro-Study-at-BSL-3-Facility-Demonstrates-P.html
http://www.ipharminc.com/press-release/2020/5/5/inhibitory-effect-of-innovation-pharmaceuticals-brilacidin-on-sars-cov-2-covid-19-in-primary-human-immune-cells-to-be-studied-at-leading-public-health-research-institute
https://finance.yahoo.com/news/innovation-pharmaceuticals-discussions-advance-brilacidin-113010295.html
https://www.globenewswire.com/news-release/2020/04/01/2009958/0/en/Innovation-Pharmaceuticals-Receives-Data-Supporting-Brilacidin-s-Direct-Inhibition-of-SARS-CoV-2-the-Novel-Coronavirus-Responsible-for-COVID-19.html
https://markets.businessinsider.com/news/stocks/innovation-pharmaceuticals-to-ship-brilacidin-to-u-s-regional-biocontainment-laboratory-for-research-against-coronavirus-covid-19-1028945690
http://www.ipharminc.com/press-release/2020/2/24/innovation-pharmaceuticals-submits-material-transfer-agreement-to-study-lead-defensin-mimetic-brilacidin-for-coronavirus-covid-19
https://www.globenewswire.com/news-release/2020/02/18/1986461/0/en/Innovation-Pharmaceuticals-Exploring-Lead-Defensin-Mimetic-Drug-Candidate-Brilacidin-as-Potential-Novel-Coronavirus-Treatment.html
https://www.globenewswire.com/news-release/2020/02/13/1984671/0/en/Innovation-Pharmaceuticals-Phase-1-Trial-of-Brilacidin-for-Ulcerative-Colitis-Meets-Primary-Endpoints-Positive-Topline-Results-of-Oral-Brilacidin.html
Market Place
Share 
